These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21084033)

  • 21. Clinical pharmacology information in summaries of product characteristics and package inserts.
    Arguello B; Fernandez-Llimos F
    Clin Pharmacol Ther; 2007 Nov; 82(5):566-71. PubMed ID: 17410119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug information for patients: bringing together the messages from prescriber, pharmacist and manufacturer.
    Herxheimer A; Davies C
    J R Coll Gen Pract; 1982 Feb; 32(235):93-7. PubMed ID: 7097632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of safety and efficacy information in drug inserts for topical prescription medications.
    Zaghi D; Maibach HI
    Am J Clin Dermatol; 2007; 8(1):43-6. PubMed ID: 17298106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A short history of patient package insert in the EU].
    Oshima K
    Yakushigaku Zasshi; 1995; 30(2):164-72. PubMed ID: 11613533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study.
    Piñero-López MÁ; Modamio P; Lastra CF; Mariño EL
    J Med Internet Res; 2016 May; 18(5):e100. PubMed ID: 27226241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Patient-oriented package inserts for drugs. Historical overview and current status].
    Van Haecht CH; Vander Stichele R; Bogaert M
    Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine.
    Pires CM; Cavaco AM
    Eur J Clin Pharmacol; 2014 May; 70(5):583-8. PubMed ID: 24458540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriate use of oral drops: perception of health professionals and assessment of package insert information.
    Zaid AN; Al-Ramahi R; Abu Ghoush A
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):854-9. PubMed ID: 21084041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of pharmacokinetic data provided in Japanese package inserts and interview forms focusing on urinary excretion of pharmacologically active species.
    Ohno Y; Kusama M; Hisaka A; Yanagihara Y; Suzuki H
    Yakugaku Zasshi; 2006 Jul; 126(7):489-94. PubMed ID: 16819270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
    Pai SA; Kshirsagar N
    J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems identified in the package leaflets of the Portuguese non-generic medicines].
    Pires C; Cavaco A; Vigário M
    Acta Med Port; 2015; 28(1):21-8. PubMed ID: 25817494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Survey of Description on Package Inserts of OTC Drugs].
    Shimauchi A; Naganuma M; Sasaoka S; Hatahira H; Motooka Y; Hasegawa S; Fukuda A; Nakao S; Sakai C; Yokoyama S; Ino Y; Nakamura M; Iguchi K
    Yakugaku Zasshi; 2018; 138(2):259-267. PubMed ID: 29386439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of patient package inserts of local and imported anti-infective agents in palestine.
    Sawalha A; Sweileh W; Zyoud Sh; Jabi S
    Libyan J Med; 2008 Dec; 3(4):181-5. PubMed ID: 21499471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishing a System for Effectively Explaining Indications for Driving Prohibition Contained in Drug Package Inserts].
    Tanaka M
    Yakugaku Zasshi; 2017; 137(3):337-340. PubMed ID: 28250330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis on descriptions of precautionary statements in package inserts of medicines.
    Nabeta K; Kimura M; Ohkura M; Tsuchiya F
    Drug Healthc Patient Saf; 2012; 4():19-25. PubMed ID: 22399866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Present state and future tasks of "Drug Guide for Patients"].
    Isozaki M
    Yakugaku Zasshi; 2015; 135(2):271-5. PubMed ID: 25747225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparative analysis of inner wrapping and package inserts for medicines containing Panax ginseng C. A. Meyer].
    Auricchio MT; Batistic-Longatto MA; Nicoletti MA
    Cad Saude Publica; 2007 Oct; 23(10):2295-304. PubMed ID: 17891291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of antidepressants during breastfeeding: evaluating drug package inserts conformity with science-based bibliographical sources].
    Pizzol TDSD; Moraes CG; Diello MV; Campos PM; Pletsch JT; Giugliani C
    Cad Saude Publica; 2019 Feb; 35(2):e00041018. PubMed ID: 30785486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.